Literature DB >> 25877600

Origin and evolution of China Pharmacopoeia and its implication for traditional medicines.

Yun-Fang Hao, Jian-Guo Jiang1.   

Abstract

Traditional Chinese Medicine (TCM) has a history that can be dated back to several thousand years ago. The extant earliest medical book is Huangdi Neijing (Canon of Internal Medicine, 770 BC~221 BC), and the earliest pharmacy monograph is Shengnong Bencao Jing (Shengnong Materia Medica, AD25~AD220). The most influential pharmacy monograph is the Bencao Gangmu (Compendium of Materia Medica, AD1368~AD1644). There were also many other far-reaching influencial monographs, which become the main and the most important derived resources of modern China pharmacopoeia for TCM. In this paper, we try to introduce some representative medicine and pharmacy works of ancient China, and elaborate the origin, development and improvement process of modern China pharmacopoeia, which may have referential significance for traditional and natural drugs. China Pharmacopoeia and TCM still have to face many problems in authenticity discrimination, action mechanism, and adverse reaction, etc. The improvement of China Pharmacopoeia still has room for progress with the solutions of modern analytical methods to the problems. The start-up and development of Herbalomics project will be helpful to further improve the China Pharmacopoeia, especially Chinese patented medicine and compound prescription.

Mesh:

Substances:

Year:  2015        PMID: 25877600     DOI: 10.2174/1389557515666150415150803

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  5 in total

1.  HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.

Authors:  Qinyuan Zhu; Yanzhou Zhang; Jiekun Xuan; Fanping Yang; Binbin Du; Sheng-An Chen; Sijia Yan; Menglin Jiang; Huizhong Zhu; Hao Xiong; Xiaoqun Luo; Qinghe Xing
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

2.  Analysis of molecular networks and targets mining of Chinese herbal medicines on anti-aging.

Authors:  Qi-Yu Jiang; Mei-Si Zheng; Xiao-Jing Yang; Xiao-Sheng Sun
Journal:  BMC Complement Altern Med       Date:  2016-12-28       Impact factor: 3.659

Review 3.  Role of gut microbiota in identification of novel TCM-derived active metabolites.

Authors:  Tzu-Lung Lin; Chia-Chen Lu; Wei-Fan Lai; Ting-Shu Wu; Jang-Jih Lu; Young-Mao Chen; Chi-Meng Tzeng; Hong-Tao Liu; Hong Wei; Hsin-Chih Lai
Journal:  Protein Cell       Date:  2020-09-15       Impact factor: 14.870

Review 4.  Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy.

Authors:  Artem Blagodatski; Margarita Yatsunskaya; Valeriia Mikhailova; Vladlena Tiasto; Alexander Kagansky; Vladimir L Katanaev
Journal:  Oncotarget       Date:  2018-06-26

5.  Association of congenital anomalies with fracture of spine, trunk, and upper and lower limbs among young people: A population-based matched cohort study in Taiwan.

Authors:  Chia-Man Ma; Lih-Hwa Lin; Hsing-Yi Chang; Pei-Chi Chou; Po-Chi Liao; Huey-Yi Chen; Kee-Ming Man; Jen-Huai Chiang; Yin-Jen Chang; Ming-Yen Tsai; Wen-Chi Chen; Yung-Hsiang Chen
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.